Cover ImageSALE
Market Research Report

Global Cardiac Monitoring Market 2017-2021

Published by TechNavio (Infiniti Research Ltd.) Product code 560861
Published Content info 102 Pages
Delivery time: 1-2 business days
Price
Back to Top
Global Cardiac Monitoring Market 2017-2021
Published: September 25, 2017 Content info: 102 Pages
Description

About Cardiac Monitoring

Cardiac monitoring refers to the continuous or intermittent observation of heart activity to determine the health of the heart. It helps diagnose cardiac arrhythmias and other heart conditions. Cardiac monitoring devices include ECG devices, cardiac event monitors, ILRs, and COM devices.

ECG devices are non-invasive diagnostic tools that are commonly used to monitor and record the electrical and muscular activity of the heart.

Technavio's analysts forecast the global cardiac monitoring market to grow at a CAGR of 8.12% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global cardiac monitoring market for 2017-2021. To calculate the market size, the report considers the revenues generated from the sales of cardiac monitoring devices.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Cardiac Monitoring Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Abbott
  • GE Healthcare
  • Hill-Rom
  • Medtronic
  • Philips Healthcare

Other Prominent Vendors

  • BioTelemetry
  • BIOTRONIK
  • Cheetah Medical
  • Deltex Medical
  • dms-service
  • Edwards Lifesciences
  • LiDCO
  • Manatec Biomedical
  • Midmark
  • NIHON KOHDEN
  • Schiller
  • SORIN GROUP
  • Spacelabs Healthcare

Market driver

  • Increasing prevalence of CVDs
  • For a full, detailed list, view our report

Market challenge

  • High cost of cardiac monitoring devices
  • For a full, detailed list, view our report

Market trend

  • Increasing number of M&A and strategic collaborations
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents
Product Code: IRTNTR14663

Table of Contents

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

  • Overview

PART 05: Market landscape

  • Overview
  • Market size and forecast
  • Five forces analysis

PART 06: Segmentation by product type

  • Overview
  • ECG devices
  • ILRs
  • Cardiac event monitors
  • COM devices

PART 07: Segmentation by geography

  • Overview
  • Americas
  • EMEA
  • APAC

PART 08: Decision framework

PART 09: Drivers and challenges

  • Market drivers
  • Market challenges

PART 10: Market trends

  • Increasing number of M&A and strategic collaborations
  • Increasing adoption of portable cardiac monitoring devices

PART 11: Vendor landscape

  • Competitive landscape

PART 12: Key vendor analysis

  • Abbott
  • GE Healthcare
  • Hill-Rom
  • Medtronic
  • Philips Healthcare
  • Other prominent vendors

PART 13: Appendix

  • List of abbreviations

List of Exhibits

  • Exhibit 01: Global cardiac monitoring market: Segmentation
  • Exhibit 02: Global cardiac monitoring market 2016-2021 ($ millions)
  • Exhibit 03: Five forces analysis
  • Exhibit 04: Global cardiac monitoring market: Segmentation by product type 2016 (% share)
  • Exhibit 05: Global ECG devices market 2016-2021 ($ millions)
  • Exhibit 06: Global ECG devices market: Segmentation by product type
  • Exhibit 07: Global ECG devices market: Segmentation by product type (% share)
  • Exhibit 08: Major resting ECG devices
  • Exhibit 09: Global resting ECG devices market 2016-2021 ($ millions)
  • Exhibit 10: Major stress ECG devices
  • Exhibit 11: Global stress ECG devices market 2016-2021 ($ millions)
  • Exhibit 12: Major Holter monitoring systems
  • Exhibit 13: Global Holter monitoring systems market 2016-2021 ($ millions)
  • Exhibit 14: Major ILRs
  • Exhibit 15: Global ILRs market 2016-2021 ($ millions)
  • Exhibit 16: Major cardiac event monitors
  • Exhibit 17: Global cardiac event monitors market 2016-2021 ($ millions)
  • Exhibit 18: Major COM devices
  • Exhibit 19: Global COM devices market 2016-2021 ($ millions)
  • Exhibit 20: Global cardiac monitoring market: Segmentation by geography 2016 (% share)
  • Exhibit 21: Cardiac monitoring market in Americas 2016-2021 ($ millions)
  • Exhibit 22: Cardiac monitoring market in EMEA 2016-2021 ($ millions)
  • Exhibit 23: Cardiac monitoring market in APAC 2016-2021 ($ millions)
  • Exhibit 24: Global cardiac monitoring market: Competitive structure analysis 2016
  • Exhibit 25: Abbott: Key highlights
  • Exhibit 26: Abbott Laboratories: Strength assessment
  • Exhibit 27: Abbott Laboratories: Strategy assessment
  • Exhibit 28: Abbott Laboratories: Opportunity assessment
  • Exhibit 29: GE Healthcare: Key highlights
  • Exhibit 30: GE Healthcare: Strength assessment
  • Exhibit 31: GE Healthcare: Strategy assessment
  • Exhibit 32: GE Healthcare: Opportunity assessment
  • Exhibit 33: Hill-Rom: Key highlights
  • Exhibit 34: Hill-Rom: Strength assessment
  • Exhibit 35: Hill-Rom: Strategy assessment
  • Exhibit 36: Hill-Rom: Opportunity assessment
  • Exhibit 37: Medtronic: Key highlights
  • Exhibit 38: Medtronic: Strength assessment
  • Exhibit 39: Medtronic: Strategy assessment
  • Exhibit 40: Medtronic: Opportunity assessment
  • Exhibit 41: Philips: Key highlights
  • Exhibit 42: Philips Healthcare: Strength assessment
  • Exhibit 43: Philips Healthcare: Strategy assessment
  • Exhibit 44: Philips Healthcare: Opportunity assessment
Back to Top